Charles River Labs Intl buy Jefferies Financial Group Inc.
Start price
09.09.25
/
50%
€134.00
Target price
09.09.26
€165.63
Performance (%)
13.84%
Price
09.03.26
€152.55
Summary
This prediction is currently active. The prediction currently has a performance of 13.84%. This prediction currently runs until 09.09.26. The prediction end date can be changed by Jefferies_Financial_ at any time. Jefferies_Financial_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Charles River Labs Intl | -1.134% | -1.134% |
| iShares Core DAX® | -2.526% | -5.194% |
| iShares Nasdaq 100 | -0.032% | 1.561% |
| iShares Nikkei 225® | -4.202% | -7.550% |
| iShares S&P 500 | -0.802% | 0.160% |
Comments by Jefferies_Financial_ for this prediction
In the thread Charles River Labs Intl diskutieren
Charles River Laboratories International (NYSE:CRL) was upgraded by analysts at Jefferies Financial Group Inc. from a "hold" rating to a "buy" rating. They now have a $195.00 price target on the stock, up previously from $142.00.
Ratings data for CRL provided by MarketBeat